By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AcelRx Pharmaceuticals 

575 Chesapeake Drive

Redwood City  California  94063  U.S.A.
Phone: 650-216-3500 Fax: 650-216-6500




Company News
AcelRx Pharmaceuticals (ACRX) Receives CE Mark Approval For Zalviso 12/2/2014 10:31:16 AM
AcelRx Pharmaceuticals (ACRX) To Participate In Four Upcoming Investor Events 11/20/2014 9:27:14 AM
AcelRx Pharmaceuticals (ACRX) Announces Zalviso™ Sublingual Sufentanil Data Presentation At The American Society Of Regional Anesthesia And Pain Medicine Meeting 11/13/2014 9:05:13 AM
AcelRx Pharmaceuticals (ACRX) Reports Third Quarter 2014 Financial Results 11/11/2014 7:42:02 AM
AcelRx Pharmaceuticals (ACRX) Receives International Standards Organization (ISO) 13485:2003 Certification Of Its Quality Management System 11/10/2014 9:59:46 AM
AcelRx Pharmaceuticals (ACRX) To Participate In Two Upcoming Investor Events 11/7/2014 8:29:36 AM
AcelRx Pharmaceuticals (ACRX) To Hold Third Quarter Financial Results Conference Call And Webcast On Monday, November 10, 2014 11/6/2014 8:37:34 AM
AcelRx Pharmaceuticals (ACRX) CEO Steps Down As Company Plots 2nd Try At Drug-Device Approval 11/5/2014 10:12:27 AM
AcelRx Pharmaceuticals (ACRX) Announces Sublingual Sufentanil Data Presentations At The American College of Surgeons Meeting 10/27/2014 8:10:01 AM
AcelRx Pharmaceuticals (ACRX)'s Zalviso Met Primary Endpoint In Phase 3 Study 10/22/2014 5:51:25 AM